Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Maternal caffeine consumption and risk of neural tube defects.

Schmidt RJ, Romitti PA, Burns TL, Browne ML, Druschel CM, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2009 Nov;85(11):879-89. doi: 10.1002/bdra.20624.

PMID:
19711421
2.

Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study.

Slickers JE, Olshan AF, Siega-Riz AM, Honein MA, Aylsworth AS; National Birth Defects Prevention Study.

Am J Epidemiol. 2008 Dec 1;168(11):1259-67. doi: 10.1093/aje/kwn248. Epub 2008 Oct 3.

3.

Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction.

Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB.

Am J Epidemiol. 2006 Jun 1;163(11):1035-41. Epub 2006 Apr 26.

4.

A hybrid design for studying genetic influences on risk of diseases with onset early in life.

Weinberg CR, Umbach DM.

Am J Hum Genet. 2005 Oct;77(4):627-36. Epub 2005 Aug 31.

5.

Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss.

Sata F, Yamada H, Suzuki K, Saijo Y, Kato EH, Morikawa M, Minakami H, Kishi R.

Mol Hum Reprod. 2005 May;11(5):357-60. Epub 2005 Apr 22.

7.

Method for using complete and incomplete trios to identify genes related to a quantitative trait.

Kistner EO, Weinberg CR.

Genet Epidemiol. 2004 Jul;27(1):33-42.

PMID:
15185401
8.

Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms.

Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH.

Epidemiology. 2004 Mar;15(2):150-6.

PMID:
15127906
9.

Guidelines for case classification for the National Birth Defects Prevention Study.

Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):193-201.

PMID:
12797461
10.

Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use.

van Rooij IA, Groenen PM, van Drongelen M, Te Morsche RH, Peters WH, Steegers-Theunissen RP.

Teratology. 2002 Nov;66(5):260-6.

PMID:
12397635
11.

DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection.

Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB.

Am J Hum Genet. 2002 Sep;71(3):528-42. Epub 2002 Aug 9.

12.
13.

The National Birth Defects Prevention Study.

Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD.

Public Health Rep. 2001;116 Suppl 1:32-40.

14.

Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses.

Signorello LB, Nordmark A, Granath F, Blot WJ, McLaughlin JK, Annerén G, Lundgren S, Ekbom A, Rane A, Cnattingius S.

Obstet Gynecol. 2001 Dec;98(6):1059-66.

PMID:
11755554
15.

Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2.

Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, Tan ZR, Zhou HH.

Pharmacogenetics. 2001 Jul;11(5):429-35.

PMID:
11470995
16.

Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.

Corchero J, Pimprale S, Kimura S, Gonzalez FJ.

Pharmacogenetics. 2001 Feb;11(1):1-6.

PMID:
11207026
17.

Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos.

Smelt VA, Upton A, Adjaye J, Payton MA, Boukouvala S, Johnson N, Mardon HJ, Sim E.

Hum Mol Genet. 2000 Apr 12;9(7):1101-7.

18.

The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.

Welfare MR, Bassendine MF, Daly AK.

Br J Clin Pharmacol. 2000 Mar;49(3):240-3.

19.
Items per page

Supplemental Content

Write to the Help Desk